NUP214 and acute lymphoblastic leukemia: NUP214::ABL1 was originally reported as a recurrent abnormality in T-ALL, accounting for 6% of adult and less than 2% of pediatric T-ALL, as recently reported by the Associazione Italiana di Onco-Ematologia Pediatrica [21].